@article{11db8c08a821451e8de6a966183223c2,
title = "Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'",
keywords = "Covid-19, ankylosing, anti-inflammatory agents, biological therapy, non-steroidal, spondylitis, sulfasalazine",
author = "Rosenbaum, {James Todd} and Weisman, {Michael H.} and Cassie Shafer and Elin Aslanyan and Howard, {Richard A.} and Kimberly Ogle and Hedley Hamilton and Reveille, {John D.} and Winthrop, {Kevin L.} and Dongseok Choi",
note = "Funding Information: Funding Web services were donated by Any-3 London. Abbvie has provided funding to the Spondylitis Association of America in support of this survey but did not participate in the design of the survey, the interpretation of results or the writing of the manuscript. We are grateful to Donna Grims, Emily Papaspyru, Adam Dale and Ian Burton, each of whom assisted in data retrieval. JTR receives support from the William and Mary Bauman Family Foundation, the Stan and Madelle Rosenfeld Family Trust, and the Grandmaison Fund for Autoimmunity Research.",
year = "2023",
month = jun,
day = "1",
doi = "10.1136/annrheumdis-2021-220588",
language = "English (US)",
volume = "82",
pages = "E138",
journal = "Annals of the rheumatic diseases",
issn = "0003-4967",
publisher = "Elsevier BV",
number = "6",
}